How do metabolites differ from their parent molecules and how are they excreted?

Journal of Chemical Information and Modeling

Volumn 53, Issue 2, 2013, Pages 354-367

  Kirchmair, Johannes ^a   Howlett, Andrew ^a   Peironcely, Julio E ^b,c,d   Murrell, Daniel S ^a   Williamson, Mark J ^a   Adams, Samuel E ^a   Hankemeier, Thomas ^c,d   Van Buren, Leo ^e   Duchateau, Guus ^e   Klaffke, Werner ^e   Glen, Robert C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d Netherlands Metabolomics Centre   (Netherlands)

^e UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURAL CHEMICALS; BIOCHEMISTRY; BIOMOLECULES; CHEMICAL ANALYSIS; MEDICINE; METABOLISM; METABOLITES; MOLECULES; TREES (MATHEMATICS);

BIOLOGICAL FUNCTIONS; DESIGN AND DEVELOPMENT; HOLISTIC PERSPECTIVES; HYDROPHILIC MOLECULES; METABOLIC REACTIONS; NUTRITIONAL SUPPLEMENTS; SMALL ORGANIC MOLECULES; TRADITIONAL CHINESE MEDICINE;

PHYSICOCHEMICAL PROPERTIES;

DRUG; HERBACEOUS AGENT;

ARTICLE; BILE; BIOTRANSFORMATION; CHEMISTRY; DRUG DATABASE; DRUG DEVELOPMENT; FECES; HUMAN; METABOLISM; METABOLOME; MOLECULAR LIBRARY; URINE;

BILE; BIOTRANSFORMATION; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; FECES; HUMANS; METABOLOME; PHARMACEUTICAL PREPARATIONS; SMALL MOLECULE LIBRARIES;

EID: 84874446059     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300487z     Document Type: Article

References (53)

1. Schroeder, K.; Bremm, K. D.; Alépée, N.; Bessems, J. G. M.; Blaauboer, B.; Boehn, S. N.; Burek, C.; Coecke, S.; Gombau, L.; Hewitt, N. J.; Heylings, J.; Huwyler, J.; Jaeger, M.; Jagelavicius, M.; Jarrett, N.; Ketelslegers, H.; Kocina, I.; Koester, J.; Kreysa, J.; Note, R.; Poth, A.; Radtke, M.; Rogiers, V.; Scheel, J.; Schulz, T.; Steinkellner, H.; Toeroek, M.; Whelan, M.; Winkler, P.; Diembeck, W. Report from the EPAA workshop: In vitro ADME in safety testing used by EPAA industry sectors Toxicol. In Vitro 2011, 25, 589-604
2. Hann, M. M.; Keserü, G. M. Finding the sweet spot: The role of nature and nurture in medicinal chemistry Nat. Rev. Drug Discovery 2012, 11, 355-365
3. Kirchmair, J.; Williamson, M. J.; Tyzack, J. D.; Tan, L.; Bond, P. J.; Bender, A.; Glen, R. C. Computational prediction of metabolism: Sites, products, SAR, P450 enzyme dynamics, and mechanisms J. Chem. Inf. Model. 2012, 52, 617-648
4. Sadowski, J.; Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs J. Med. Chem. 1998, 41, 3325-3329
5. Ajay, A.; Walters, W. P.; Murcko, M. A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem. 1998, 41, 3314-3324
6. Henkel, T.; Brunne, R. M.; Müller, H.; Reichel, F. Statistical investigation into the structural complementarity of natural products and synthetic compounds Angew. Chem., Int. Ed. 1999, 38, 643-647
7. Feher, M.; Schmidt, J. M. Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry J. Chem. Inf. Comput. Sci. 2003, 43, 218-227
8. Stahura, F. L.; Godden, J. W.; Xue, L. Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations J. Chem. Inf. Comput. Sci. 2000, 40, 1245-1252
9. Dobson, P. D.; Patel, Y.; Kell, D. B. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries Drug Discovery Today 2009, 14, 31-40
10. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46, 3-26
11. Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 2002, 45, 2615-2623
12. Brüstle, M.; Beck, B.; Schindler, T.; King, W.; Mitchell, T.; Clark, T. Descriptors, physical properties, and drug-likeness J. Med. Chem. 2002, 45, 3345-3355
13. Oprea, T. I. Current trends in lead discovery: Are we looking for the appropriate properties? J. Comput.-Aided Mol. Des. 2002, 16, 325-334
14. Oprea, T. I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. Is there a difference between leads and drugs? A historical perspective J. Chem. Inf. Comput. Sci. 2001, 41, 1308-1315
15. Chen, H.; Engkvist, O.; Blomberg, N.; Li, J. A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds MedChemComm 2012, 3, 312
16. Khanna, V.; Ranganathan, S. Physiochemical property space distribution among human metabolites, drugs and toxins BMC Bioinf. 2009, 10 (Suppl 1) S10
17. Lee, M. L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries J. Comb. Chem. 2001, 3, 284-289
18. Peironcely, J. E.; Reijmers, T.; Coulier, L.; Bender, A.; Hankemeier, T. Understanding and classifying metabolite space and metabolite-likeness PloS ONE 2011, 6, e28966
19. van de Waterbeemd, H.; Camenisch, G.; Folkers, G.; Chretien, J. R.; Raevsky, O. A. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and h-bonding descriptors J. Drug. Target 1998, 6, 151-165
20. Gleeson, M. P. Generation of a set of simple, interpretable ADMET rules of thumb J. Med. Chem. 2008, 51, 817-834
21. Benet, L. Z.; Broccatelli, F.; Oprea, T. I. BDDCS applied to over 900 drugs AAPS J. 2011, 13, 519-547
22. Khanna, V.; Ranganathan, S. Structural diversity of biologically interesting datasets: A scaffold analysis approach J. Cheminf. 2011, 3:30
23. Nobeli, I.; Ponstingl, H.; Krissinel, E. B.; Thornton, J. M. A structure-based anatomy of the E. coli metabolome J. Mol. Biol. 2003, 334, 697-719
24. Hattori, M.; Okuno, Y.; Goto, S.; Kanehisa, M. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways J. Am. Chem. Soc. 2003, 125, 11853-11865
25. Gupta, S.; Aires-de-Sousa, J. Comparing the chemical spaces of metabolites and available chemicals: Models of metabolite-likeness Mol. Diversity 2007, 11, 23-36
26. Ertl, P.; Roggo, S.; Schuffenhauer, A. Natural product-likeness score and its application for prioritization of compound libraries J. Chem. Inf. Model. 2008, 48, 68-74
27. Eckert, H.; Bajorath, J. Exploring peptide-likeness of active molecules using 2D fingerprint methods J. Chem. Inf. Model. 2007, 47, 1366-1378
28. Hao, G.; Dong, Q.; Yang, G. A comparative study on the constitutive properties of marketed pesticides Mol. Inf. 2011, 30, 614-622
29. Medina-Franco, J. L. Interrogating novel areas of chemical space for drug discovery using chemoinformatics Drug Dev. Res. 2012, 73, 430-438
30. Shen, M.; Tian, S.; Li, Y.; Li, Q.; Xu, X.; Wang, J.; Hou, T. Drug-likeness analysis of traditional Chinese medicines: 1. Property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines J. Cheminf. 2012, 4:31
31. Lopez-Vallejo, F.; Giulianotti, M. A.; Houghten, R. A.; Medina-Franco, J. L. Expanding the medicinally relevant chemical space with compound libraries Drug Discovery Today 2012, 17, 718-726
32. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. Drugbank 3.0: A comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 2011, 39, D1035-1041
33. Wishart, D. S.; Knox, C.; Guo, A. C.; Eisner, R.; Young, N.; Gautam, B.; Hau, D. D.; Psychogios, N.; Dong, E.; Bouatra, S.; Mandal, R.; Sinelnikov, I.; Xia, J.; Jia, L.; Cruz, J. A.; Lim, E.; Sobsey, C. A.; Shrivastava, S.; Huang, P.; Liu, P.; Fang, L.; Peng, J.; Fradette, R.; Cheng, D.; Tzur, D.; Clements, M.; Lewis, A.; De Souza, A.; Zuniga, A.; Dawe, M.; Xiong, Y.; Clive, D.; Greiner, R.; Nazyrova, A.; Shaykhutdinov, R.; Li, L.; Vogel, H. J.; Forsythe, I. HMDB: A knowledgebase for the human metabolome Nucleic Acids Res. 2009, 37, D603-D610
34. Chen, C. Y. C. TCM Database @Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico PloS ONE 2011, 6, e15939
35. Accelrys Metabolite Database, version 2011.2; Accelrys, Inc.: San Diego, CA, 2011.
36. MOE, 2010.10; Chemical Computing Group: Montreal, QC, 2011.
37. Adams, S. E. Molecular similarity and xenobiotic metabolism. Ph.D. Thesis. University of Cambridge, UK. 2010.
38. MetaPrint2D. http://www-metaprint2d.ch.cam.ac.uk (accessed Dec 11, 2012).
39. Waring, M. J. Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower logD limits based on permeability Bioorg. Med. Chem. Lett. 2009, 19, 2844-2851
40. Gleeson, M. P.; Hersey, A.; Montanari, D.; Overington, J. Probing the links between in vitro potency, ADMET and physicochemical parameters Nat. Rev. Drug Discovery 2011, 10, 197-208
41. Benet, L.; Broccatelli, F.; Oprea, T. BDDCS applied to over 900 drugs AAPS J. 2011, 13, 519-547
42. Sutherland, J. J.; Raymond, J. W.; Stevens, J. L.; Baker, T. K.; Watson, D. E. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes J. Med. Chem. 2012, 55, 6455-6466
43. Hughes, J. D.; Blagg, J.; Price, D. A.; Bailey, S.; Decrescenzo, G. A.; Devraj, R. V.; Ellsworth, E.; Fobian, Y. M.; Gibbs, M. E.; Gilles, R. W.; Greene, N.; Huang, E.; Krieger-Burke, T.; Loesel, J.; Wager, T.; Whiteley, L.; Zhang, Y. Physiochemical drug properties associated with in vivo toxicological outcomes Bioorg. Med. Chem. Lett. 2008, 18, 4872-4875
44. Bar-Even, A.; Noor, E.; Flamholz, A.; Buescher, J. M.; Milo, R. Hydrophobicity and charge shape cellular metabolite concentrations PLoS Comput. Biol. 2011, 7, e1002166
45. Irwin, J. J.; Shoichet, B. K. ZINC-a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182
46. Guengerich, F. P. Human cytochrome P450 enzymes. In Cytochrome P450: Structure, mechanism, and biochemistry, 3 rd ed.; Ortiz de Montellano, P. R., Ed.; Kluwer Academic/Plenum Publishers: New York, 2005; pp 377-530.
47. Wilkinson, G. R. Drug metabolism and variability among patients in drug response N. Engl. J. Med. 2005, 352, 2211-2221
48. Slaughter, R. L.; Edwards, D. J. Recent advances: The cytochrome P450 enzymes Ann. Pharmacother. 1995, 29, 619-624
49. Oesch, F.; Fabian, E.; Oesch-Bartlomowicz, B.; Werner, C.; Landsiedel, R. Drug-metabolizing enzymes in the skin of man, rat, and pig Drug Metab. Rev. 2007, 39, 659-698
50. Svensson, C. K. Biotransformation of drugs in human skin Drug Metab. Dispos. 2009, 37, 247-253
51. Spalding, D. The importance of the physicochemical properties of drugs to drug metabolism. In A handbook of bioanalysis and drug metabolism, Evans, G., Ed.; CRC Press: Boca Raton, 2004; pp 8-31.
52. Gordon Gibson, G.; Skett, P. Introduction to drug metabolism, 3 rd ed.; Cengage Learning: Andover, 2001; pp 37-86.
53. Carlsson, L.; Spjuth, O.; Adams, S.; Glen, R. C.; Boyer, S. Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse BMC Bioinf. 2010, 11, 362-362